Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000250
Chunk: 100

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 100
---
 other jurisdictions; |
| ● | successfully collaborate with institutions in the discovery, development and commercialization of its products; and                                            |
| ● | successfully expand its operations and implement a successful sales and marketing strategy to support commercialization.                                       |

Renovaro
Cube may not be able to compete effectively if Renovaro Cube is unable to accomplish one or more of these or similar objectives.

<div align='center'>53</div>

If Renovaro Cube cannot enter new collaborations in a timely manner and on acceptable terms, its efforts to develop and commercialize its products could be delayed or adversely affected.

From time
to time, Renovaro Cube expects to engage in discussions with potential development and/or commercial collaborators that may or may not
lead to collaborations. However, Renovaro Cube cannot guarantee that any discussions will result in development or commercial collaborations.
Further, once news of discussions regarding possible collaborations are known in the general public, regardless of whether the news is
accurate, failure to announce a collaboration agreement, or the entity’s announcement of a collaboration with an entity other than
Renovaro Cube, could result in adverse speculation about Renovaro Cube, its products or its technology, resulting in harm to its reputation
and its business. In addition, establishing collaborations is difficult and time-consuming and may require Renovaro Cube’s
significant financial investment. Potential collaborators may elect not to work with Renovaro Cube based on their assessment of its financial,
regulatory, or intellectual property position. Even if Renovaro Cube establishes new collaborations, they may not result in the successful
development or commercialization of its products or technology.

If Renovaro Cube is unable to establish sales and marketing capabilities, it may not be successful in commercializing Renovaro Cube’s products.

Renovaro
Cube has only limited sales and marketing infrastructures and no experience as a company in the sale, marketing and distribution of screening
or diagnostic tests. In preparation of a commercial launch, Renovaro Cube is rapidly hiring additional personnel in Renovaro Cube’s
sales and marketing organization.

Factors that may inhibit
Renovaro Cube’s efforts to commercialize any of its products include:

| ● | its inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer service, medical affairs and other support personnel; |
| ● | the inability of sales personnel to persuade adequate numbers of customers, including healthcare systems and healthcare providers, to use its products;           |
| ● | the inability to price its products at a sufficient